Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Clostridium formicaceticum - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , Html Article Publication |
| Increases Clostridium formicaceticum - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Berberine alleviates ETEC-induced intestinal inflammation and oxidative stress damage by optimizing intestinal microbial composition in a weaned piglet model. Frontiers in immunology (Front Immunol ) Vol: 15 Issue Pages: 1460127 Pub: 2024 Epub: 2024 Sep 16 Authors Wang Y , Zhang Z , Du M , Ji X , Liu X , Zhao C , Pang X , Jin E , Wen A , Li S , Zhang F , Html Article Publication |
| Decreases Clostridium formicaceticum - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Berberine alleviates cholesterol and bile acid metabolism disorders induced by high cholesterol diet in mice. Biochemical and biophysical research communications (Biochem Biophys Res Commun ) Vol: 719 Issue Pages: 150088 Pub: 2024 Jul 30 Epub: 2024 May 8 Authors Wang Q , Shen W , Shao W , Hu H , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
